Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
There is an upward development for Zealand Pharma A/s compared to yesterday, with an increase of €1.12 (2.660%).
So far the community has only identified positive things for Zealand Pharma A/s stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 2.660% | 7.136% | 10.923% | -25.461% | -34.292% | 42.123% | 52.873% |
| Saniona AB | 0.710% | -3.476% | -4.839% | 165.666% | -26.173% | 100.567% | -34.444% |
| Ocuphire Pharma Inc. | -0.430% | 9.955% | 10.204% | 573.130% | 188.942% | -0.103% | - |
| Immunic Inc. | 3.510% | -22.364% | -15.613% | 2.644% | 98.605% | -34.105% | -92.836% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
